Chuikyo Releases New Round Of Price Listings In Japan
This article was originally published in PharmAsia News
Executive Summary
BMS’ Orencia, Sanofi’s Lyxumia, Chugai’s Perjeta and others are now cleared for the market after receiving National Health Insurance price listings.